ArticleOncology letters2018

ATPase inhibitory factor 1 inhibition improves the antitumor of YC-1 against hepatocellular carcinoma.

Xuemei Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.